Worth reading
61In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
3435000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance and exercise of the 14th Stock Acquisition Rights issued through a third-party allotment with an exercise price adjustment clause
発行・処分する株式数3,435,000Shares
Shares delivered since the beginning of the month: 3,435,000 new shares. No treasury shares were transferred.
Intended allottee
Nagasawa Makoto (長澤誠) (allottee at the time of issuance)
発行済株式総数
Exercise ratio subject to the exercise restriction: 9.99% (3,435,000 delivered shares / 34,350,389 listed shares as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥38.0. Details of the exercise price adjustment clause and the lower exercise price are Not disclosed in this document.
Number of Stock Acquisition Rights
Total issued: 187,000 rights. Unexercised at the beginning of the month: 101,850 rights; unexercised as of the current date: 67,500 rights
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
15 December 2023: Issuance of the 14th Stock Acquisition Rights with an exercise price adjustment clause. Total issued: 187,000 rights. Amount: Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance and exercise of the 14th Stock Acquisition Rights issued through a third-party allotment with an exercise price adjustment clause |
| Number of shares to be issued or disposed of | Shares delivered since the beginning of the month: 3,435,000 new shares. No treasury shares were transferred. |
| Intended allottee | Nagasawa Makoto (長澤誠) (allottee at the time of issuance) |
| Dilution Rate | Exercise ratio subject to the exercise restriction: 9.99% (3,435,000 delivered shares / 34,350,389 listed shares as of the payment date for the issuance) |
| Total number of issued shares | 106,394,569 shares (as of the end of the month preceding the relevant period, including 16 treasury shares) → Not disclosed |
| Exercise price | ¥38.0. Details of the exercise price adjustment clause and the lower exercise price are Not disclosed in this document. |
| Number of Stock Acquisition Rights | Total issued: 187,000 rights. Unexercised at the beginning of the month: 101,850 rights; unexercised as of the current date: 67,500 rights |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | 15 December 2023: Issuance of the 14th Stock Acquisition Rights with an exercise price adjustment clause. Total issued: 187,000 rights. Amount: Not disclosed |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The 14th Stock Acquisition Rights issued on 15 December 2023 were substantially exercised during the relevant period.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.